Edition:
United States

Vical Inc (VICL.OQ)

VICL.OQ on NASDAQ Stock Exchange Capital Market

2.43USD
18 Aug 2017
Change (% chg)

$0.03 (+1.25%)
Prev Close
$2.40
Open
$2.40
Day's High
$2.43
Day's Low
$2.37
Volume
1,977
Avg. Vol
11,087
52-wk High
$4.38
52-wk Low
$2.06

Latest Key Developments (Source: Significant Developments)

Vical Inc Q2 loss per share $0.30
Tuesday, 8 Aug 2017 06:30am EDT 

Aug 8 (Reuters) - Vical Inc :Vical reports second quarter 2017 financial and operational results.Q2 loss per share $0.30.Q2 revenue $3.4 million versus $4.1 million.  Full Article

Vical Inc names Anthony Ramos CFO
Thursday, 1 Jun 2017 06:58am EDT 

June 1 (Reuters) - Vical Inc :Vical Inc says on May 25, 2017, board appointed Anthony A. Ramos, company's chief accounting officer, to be company's chief financial officer.In the role as CFO, Ramos will also serve as co's principal financial officer, principal accounting officer, replacing Vijay B. Samant as co's CFO.  Full Article

Vical Q1 loss per share $0.25
Monday, 15 May 2017 06:30am EDT 

May 15 (Reuters) - Vical Inc :Vical reports first quarter 2017 financial results.Q1 loss per share $0.25.Q1 revenue $3.2 million versus $4.6 million.Vical had cash and investments of $39.2 million at March 31, 2017.Vical Inc- company's net cash burn for Q1 of 2017 was $1.8 million, which was consistent with company's full year guidance of between $8 million and $11 million.  Full Article

AnGes MG plans cooperation with Vical Inc on development of genetic medication for Chronic Hepatitis B
Tuesday, 4 Apr 2017 04:06am EDT 

AnGes MG Inc <4563.T> :Says co enters into a cooperation contract with a US-based firm Vical Incorporated, on joint development of genetic medication for treatment of Chronic Hepatitis B.  Full Article

Vical reports Q4 revenue of $3.2 million
Thursday, 9 Mar 2017 06:30am EST 

Vical Inc : Vical reports fourth quarter 2016 financial results . Q4 loss per share $0.25 . Q4 revenue $3.2 million versus $6.8 million .Vical Inc- Company is projecting net cash burn for 2017 between $8 million and $11 million.  Full Article

AnGes MG signs strategic business alliance agreement with Vical
Thursday, 8 Dec 2016 03:17am EST 

AnGes MG Inc <4563.T>:Says it signed strategic business alliance agreement for DNA vaccine, with Vical Inc on Dec. 8.  Full Article

Vical reports Q3 loss per share $0.24
Thursday, 3 Nov 2016 06:30am EDT 

Vical Inc - : Vical Inc says projecting net cash burn for 2016 between $8 million and $11 million . Vical reports third quarter 2016 financial results . Q3 loss per share $0.24 .Q3 revenue $2.6 million versus $5.0 million.  Full Article

Vical Q2 loss per share $0.14
Tuesday, 9 Aug 2016 06:30am EDT 

Vical Inc : Q2 loss per share $0.14 . Vical reports second quarter 2016 financial results . Q2 revenue $4.1 million versus $4.2 million .Projecting net cash burn for 2016 between $8 million and $11 million.  Full Article

Vical announces $7.8 mln equity investment by partner Anges MG
Monday, 1 Aug 2016 06:30am EDT 

Vical Inc : Vical announces $7.8 million equity investment by partner, Anges MG . Shares are being sold at a price of $4.24 per share .With new investment, Anges' equity position in Vical will increase from 2.4% to approximately 18.6% of Vical's outstanding shares.  Full Article

Vical's phase 1/2 trial data shows bivalent vaccine imparts reduction in genital herpes lesions durable to 9 months
Monday, 20 Jun 2016 11:15am EDT 

Vical Inc : Initial top line 3-month data announced in june 2015 showed neither monovalent nor bivalent vaccine met primary endpoint of viral shedding rate reduction from baseline . Vaccine achieved statistically significant reduction in prospectively defined secondary endpoint of genital lesion rate at 3 months versus baseline . Plan to initiate a phase 2 trial of bivalent vaccine during second half of 2016 . Maintain our guidance for net cash burn of between $8 million and $11 million during 2016 .Vical's phase 1/2 trial data presented at asm 2016 shows bivalent vaccine imparts reduction in genital herpes lesions durable to 9 months.  Full Article

BRIEF-Vical Inc Q2 loss per share $0.30

* Vical reports second quarter 2017 financial and operational results